Lanspro 15 Tablet DT contains Lansoprazole 15 mg, a proton pump inhibitor used to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal and gastric ulcers, Zollinger-Ellison syndrome, and other conditions associated with excessive stomach acid production. Lansoprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme system located on the gastric parietal cell surface, thereby suppressing the final step of acid production. The disintegrating tablet formulation allows for rapid dissolution in the oral cavity without the need for water, improving patient compliance, especially in those with swallowing difficulties. Lanspro 15 is typically administered once daily before meals, with the dosage and duration depending on the specific indication and patient response. Common adverse effects include headache, diarrhea, abdominal pain, and nausea, which are generally mild and transient. Caution is advised in patients with hepatic impairment, and long-term use should be monitored due to potential risks such as vitamin B12 deficiency and increased susceptibility to gastrointestinal infections. Lanspro 15 Tablet DT should be used under medical supervision, adhering to prescribed dosing to ensure optimal therapeutic outcomes.